Basic info
Industry
biotechnology research
Sectors
Biotechnology
chronic wounds
matrix therapy
ARDS
ischemic stroke
CACICOL20®
RGTA®
healing
CACIPLIQ20®
corneal lesions
ReGeneraTing Agents
Regenerative medicine
Date founded
2000
Funding rounds raised
Total raised
$3.9M
from 1 investors over 1 rounds
O
OTR3 raised $3.9M on October 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)